DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE

Somerset Therapeutics, LLC🇺🇸 United States

FDA Page

Effective Date: Dec 18, 2023
Approval ID: 17f04726-725f-4839-911d-47fc5e02baae
Products: 1 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE OPHTHALMIC SOLUTION safely and effectively. SEE FULL PRESCRIBING INFORMATION FOR DORZOLAMIDE HYDROCHLORIDE and TIMOLOL MALEATE OPHTHALMIC SOLUTION. DORZOLAMIDE HYDROCHLORIDE AND TIMOLOL MALEATE ophthalmic solution, for topical ophthalmic use.Initial U.S. Approval: 1998

Quick Stats

Total Products1

Labelers2

Label Sections18

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.